About

Prof Dr Andreas Felder’s in-house role with the legal team of Boehringer Ingelheim saw him move from his initial role as a legal counsel to head of corporate legal biopharma over the course of an eleven-year period prior to him joining Vetter Pharma as vice president legal & corporate compliance and general counsel in 2016. ‘Working for Boehringer Ingelheim in Germany and the United States and being part of a US site leadership team, the global biopharma leadership team and several legal management teams, as well as having worldwide responsibility for all legal topics of the biopharma business of the company was definitely a career highlight’, he says of this period of his career. With Vetter Pharma, Prof Dr Felder continued to develop the legal and compliance department as a proactive, helpful partner that is a benefit for the company and which is proactively contacted by the internal business partners. Over the long term, he believes that ‘lean legal processes, legal tech and legal operations management will continue to assume greater importance, particularly when it comes to doing “more with less” and to provide lean and proper risk management solutions’. In addition, ‘cooperation with external law firms will dramatically change’.